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Socioeconomic deprivation is known to be associated with worse outcomes in asthma, but
there is a lack of population-based evidence of its impact across all stages of patient care.
We investigated the association of socioeconomic deprivation with asthma-related care and
outcomes across primary and secondary care and with asthma-related death in Wales.
Methods and findings
We constructed a national cohort, identified from 76% (2.4 million) of the Welsh population,
of continuously treated asthma patients between 2013 and 2017 using anonymised, per-
son-level, linked, routinely collected primary and secondary care data in the Secure Anon-
ymised Information Linkage (SAIL) Databank. We investigated the association between
asthma-related health service utilisation, prescribing, and deaths with the 2011 Welsh Index
of Multiple Deprivation (WIMD) and its domains. We studied 106,926 patients (534,630 per-
son-years), 56.3% were female, with mean age of 47.5 years (SD = 20.3). Compared to the
least deprived patients, the most deprived patients had slightly fewer total asthma-related
primary care consultations per patient (incidence rate ratio [IRR] = 0.98, 95% CI 0.97–0.99,
p-value < 0.001), slightly fewer routine asthma reviews (IRR = 0.98, 0.97–0.99, p-value <
0.001), lower controller-to-total asthma medication ratios (AMRs; 0.50 versus 0.56, p-value
< 0.001), more asthma-related accident and emergency (A&E) attendances (IRR = 1.27,
1.10–1.46, p-value = 0.001), more asthma emergency admissions (IRR = 1.56, 1.39–1.76,
p-value < 0.001), longer asthma-related hospital stay (IRR = 1.64, 1.39–1.94, p-value <
0.001), and were at higher risk of asthma-related death (risk ratio of deaths with any mention
of asthma 1.56, 1.18–2.07, p-value = 0.002). Study limitations include the deprivation index
being area based and the potential for residual confounders and mediators.
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Conclusions
In this study, we observed that the most deprived asthma patients in Wales had different
prescribing patterns, more A&E attendances, more emergency hospital admissions, and
substantially higher risk of death. Interventions specifically designed to improve treatment
and outcomes for these disadvantaged groups are urgently needed.
Author summary
Why was this study done?
• Income, education, and region of living are known to affect a person’s health, and stud-
ies around the world found links between asthma and these socioeconomic factors.
• However, little is known about how the different types of socioeconomic disadvantage
affect asthma across the lifetime.
What did the researchers do and find?
• We studied 106,926 people with treated asthma in Wales for 5 years and used an official
metric to rank areas of residence by wealth, education, and other factors.
• We analysed the links between this metric and how often people with asthma go to gen-
eral practitioners (GP), receive medications, or suffered severe asthma attacks. We also
analysed the link with asthma death in 327,906 people with asthma.
• We found worse asthma outcomes in the more disadvantaged areas, especially those
with lower levels of wealth, employment, and education.
• In the most disadvantaged areas, people went more often to emergency departments for
asthma, were approximately 50% more likely to be admitted to hospital and die from
asthma, had a slightly worse balance of asthma medications with lower ratios of control-
ler-to-total asthma medications, and were 3 times more likely to take 12 or more reliever
inhalers per year compared to people in the least disadvantaged areas.
What do these findings mean?
• People with asthma in the more disadvantaged areas have worse control of the disease,
experience more asthma attacks, and are at higher risk of death from asthma.
• Lack of educational opportunities likely affects how well people manage their asthma
and put them at higher risk of asthma attacks and death.
• The socioeconomic gap in asthma could be mitigated with GP encouragement of people
to receive and take enough preventing medications and self-manage their asthma well
regardless of background, and with wider policies to provide equal educational opportu-
nities across society.
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Introduction
Asthma is one of the most prevalent chronic diseases and has significant clinical and economic
burden [1]. However, asthma burden is not evenly distributed within populations, and socio-
economic variations in asthma prevalence, emergency hospital admissions, and mortality have
been recorded worldwide [2–4]. These variations have been attributed to a range of modifiable
and non-modifiable factors. Ethnicity has been found to partly explain the higher asthma prev-
alence, disease severity, and risk of asthma admissions among South Asians and Afro-Carib-
beans in the United Kingdom [5,6] and African-Americans and Puerto Ricans in the United
States [7]. However, lower household income has been identified as an independent risk factor
for the development of persistent asthma among children [8] and for worse asthma outcomes
[9]. Suboptimal asthma self-management and worse asthma outcomes have been associated
with lower health literacy [10–12]. Air quality has also been linked to asthma severity [13,14],
although the literature on its association with asthma incidence and prevalence is inconclusive
[15,16].
The UK has a high asthma prevalence and burden [1] and persistent socioeconomic
inequalities where the more deprived people had worse asthma outcomes including higher
risk of emergency admissions and deaths due to asthma [3,17]. In Wales, previous studies
found that severe asthma admissions were more likely in the most deprived areas [18,19],
which was attributed to active or passive smoking, variations in disease management, and air
pollution. However, asthma is mostly managed in primary care in the UK with hospital care
reserved for those with more severe disease or, most commonly, in the context of asthma
attacks. Therefore, in order to comprehensively investigate inequalities in asthma care in this
country, there is a need to study asthma care provision across care sectors. There is currently
sparse evidence on the socioeconomic inequalities in asthma-related primary care, prescribing,
accident and emergency (A&E) use, and deaths across the different demographic groups.
In this study, we investigated socioeconomic variations in asthma care and outcomes in
Wales, including asthma-related primary and secondary health service utilisation, prescribing,




Research ethics approval was not required as we only used anonymised data. The Secure
Anonymised Information Linkage (SAIL) Databank independent Information Governance
Review Panel approved the study as part of the Wales Asthma Observatory project.
Study design and data sources
We undertook a national, linked primary and secondary care retrospective cohort study of
people with asthma in Wales. The follow-up period was 5 years from January 1, 2013 to
December 31, 2017.
We used anonymised linked person-level datasets about primary and secondary care and
causes of death from the Wales-wide SAIL Databank [20,21]. SAIL has 100% coverage in
Wales for secondary care and causes of death and receives data from over 76% of the Welsh
general practices. S1 Text provides more details about data sources and study design, and S2
Text details criteria of patient selection. S1 Table lists the code sets used in the patient selection
and extraction of variables.
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Guidelines Network; COPD, chronic obstructive
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maximum likelihood; GAM, generalised additive
model; GP, general practitioner; ICD-10, 10th
Revision of the International Classification of
Diseases; ICS, inhaled corticosteroids; IRR,
incidence rate ratio; LABA, long-acting beta-
adrenoceptor agonist; LOS, length of stay; LSOA,
Lower layer Super Output Area; NB, negative
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health Data; SABA, short-acting beta-adrenoceptor
agonist; SAIL, Secure Anonymised Information
Linkage; STROBE, Strengthening the Reporting of
Observational Studies in Epidemiology; WIMD,
Welsh Index of Multiple Deprivation; WLGP, Welsh
Longitudinal General Practice.
Variables
Socioeconomic status. We measured socioeconomic status using the 2011 version of the
Welsh Index of Multiple Deprivation (WIMD), the official area-based measure of relative
socioeconomic deprivation in Wales [22]. The WIMD 2011 was constructed from a weighted
sum of 8 deprivation domains: income (23.5%), employment (23.5%), health (14.0%), educa-
tion (14.0%), geographical access to services (10.0%), housing (5.0%), physical environment
(5.0%), and community safety (5.0%). The WIMD 2011 is based on Lower Layer Super Output
Areas (LSOAs) which is a small area geography designed by the UK Office for National Statis-
tics (ONS) for census-related purposes with consistent population sizes (1,500 people on aver-
age) [22]. We linked the patients to the WIMD through their residential addresses (LSOAs of
the 2001 Census [23]) during the follow-up period. Where more than 1 address existed, we
selected the address with the longest duration within that period. Quintiles of score were
coded from 1 for the most deprived to 5 for the least deprived. S1 Fig shows the distribution of
the WIMD 2011 score and its quintiles.
Asthma-related health service utilisation. Asthma-related health service utilisation was
measured as counts of the corresponding primary and secondary care events, length of stay
(LOS) in hospital, and controller-to-total asthma medication ratio (AMR) during the follow-
up period.
We defined an “asthma-related general practitioner (GP) consultation” as 1 or more Read
codes that indicated asthma-related contact with primary care professionals.
An asthma review was defined as scheduled consultations to a primary care practice in
which disease control is assessed, and management plan, prescriptions, and asthma self-man-
agement advice were reviewed. The British Thoracic Society/the Scottish Intercollegiate
Guidelines Network (BTS/SIGN) Guidelines on the Management of Asthma recommends that
asthma reviews be arranged at least annually [24]. We identified routine asthma reviews from
the Welsh Longitudinal General Practice (WLGP) dataset using codes of annual review, medi-
cation review, follow-up, monitoring by nurse, and review using the Royal College of Physi-
cians’ 3 Questions for Asthma [25].
We identified asthma-related A&E attendances with primary or secondary diagnosis of
asthma from the Emergency Department Data Set using the dataset-specific asthma code 14A.
We identified asthma admissions from the Patient Episode Database for Wales as those
with a primary diagnosis of asthma (J45) or status asthmaticus (J46) coded using the 10th Revi-
sion of the International Classification of Diseases (ICD-10). Among these, emergency admis-
sions were defined as coming via A&E departments, urgent referrals from GPs, consultant
clinics, bed bureaus, or NHS Direct [26].
Asthma medication ratio. The AMR, the ratio of controller-to-total asthma prescrip-
tions, has been developed in the US as a surrogate quality measure of guideline adherence and
is associated with patient outcomes and health service utilisation [27]. AMR calculation
included counts of inhaled corticosteroids (ICS), ICS-long-acting beta adrenoceptor agonist
(LABA) combination inhalers, sodium cromoglicate, and nedocromil as controller prescrip-
tions, and short-acting beta agonist (SABA) inhalers as rescue prescriptions over the follow-up
period. The formula was (ICS + ICS_LABA + sodium cromoglicate + nedocromil)/(ICS
+ ICS_LABA + sodium cromoglicate + nedocromil + SABA).
Asthma-related death. We used 2 definitions for asthma deaths: (1) deaths with any men-
tion of asthma (an ICD-10 code of J45 or J46) in the death record; and (2) deaths with asthma
as the underlying cause. Unlike the other outcomes, we analysed asthma deaths in a wider
cohort of people with asthma diagnosed before the study period (see S2 Text).
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Statistical analysis
For the source population, we described demographics, point prevalence of ever being diag-
nosed with asthma (i.e., having an asthma diagnosis Read code) on January 1, 2013, and the
period prevalence of ever-diagnosed currently treated asthma during 2013 (having an asthma
diagnosis Read code ever and at least 1 asthma prescription code during 2013).
For the study cohort, we calculated the distribution, by the WIMD quintile, of age, gender,
receipt of asthma prescription categories, and the health service utilisation variables. For
AMR, we excluded patients who did not receive any of the prescriptions in the formula.
For each health service utilisation count variable, we fitted a negative binomial (NB) general-
ised linear model using the glm.nb function from the MASS package (version 7.3–51.4) [28]. We
considered the least deprived quintile (WIMD 5) as the reference group. We adjusted the models
for gender and age at the start of follow-up. We treated LOS in hospital as a count variable (count
of days) for which the model coefficient represents the incidence rate ratio (IRR) of incurring an
additional day in hospital in a given quintile compared with the least deprived quintile. Model fit
was examined using quantile–quantile (Q–Q) plots of raw residuals and rootograms [29]. These
models were specified a priori. However, we performed 2 separate sensitivity analyses; in the first
one, we removed the condition of having continuous asthma treatment over the follow-up period,
and in the second one, we removed the condition of continuous follow-up in the primary care
dataset. We also modelled these count outcome variables using generalised additive models
(GAMs) using the R package mgcv (version 1.8–31) [30]. We initially estimated global smooths
for both the overall WIMD score and age. Then, we explored the within-gender effect of the over-
all WIMD score by estimating separate smooths for males and females. From these, we calculated
a difference smooth [31] to explore the between-gender variation in the effect of the overall
WIMD score. We then modelled the interaction between the overall WIMD score and age using a
full tensor product smooth (mgcv::te). The count variables were also modelled separately against
the score of each WIMD domains, controlled for age and gender.
We compared the mean AMR between the most and least deprived quintiles using Welch t
test. Then, we fitted a GAM using the beta regression family (mgcv::betar), adjusted for age
and gender, to explore the associations with the overall WIMD score.
We modelled each definition of asthma deaths using logistic regression of WIMD quintile
adjusted for gender and age. The effect of gender was then examined in separate models within
each WIMD quintile. We then fitted binomial GAM models, including global smooths for the
overall WIMD score and age, smooths by gender, and a difference smooth by gender, and
compared the overall fitted risk of asthma death between males and females across the overall
WIMD score. Finally, asthma deaths were then modelled separately against the score of each
WIMD domains, controlled for age and gender.
All the GAMs in this paper used a thin plate regression spline as a smoothing basis and the
fast restricted maximum likelihood (fREML) computation as a smoothing parameter estima-
tion method.
We compared the ratio of overall emergency-to-total hospitalisations for asthma between
the WIMD quintiles using equality of proportions test.
We used a confidence level of 95% (p< 0.05, 2-sided) throughout the study. All data analy-
sis was performed in R 4.0.2.
Reporting and supporting reproduction
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) [32] and the REporting of studies Conducted using Observational Rou-
tinely-collected health Data (RECORD) [33] guidelines (S1 Checklist).
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The computer code used for data extraction and analysis is publicly available on GitHub
[34].
Study planning
Investigating asthma inequalities in Wales was a planned part of the first author’s doctoral the-
sis about creating and utilising the Wales Asthma Observatory. There was no prospective pro-
tocol for the study. Health service utilisation count regression models against the WIMD 2011
score quintile were specified a priori, and preliminary results for an earlier follow-up period
were previously published [35,36]. To provide a more comprehensive picture about inequali-
ties, the analysis was developed to include wider outcomes such as asthma emergency admis-
sions, prescribing, and deaths as well as the WIMD 2011’s individual domains as predictors.
The GAMs were developed in response to a peer review request to investigate nonlinear
associations.
Results
Table 1 shows characteristics of the source population (n = 2,871,257). The prevalence of ever-
diagnosed asthma in the source population at the beginning of 2013 was 11.9% (95% CI, 11.8
to 11.9), with 12.5% (12.5 to 12.6) in the most deprived areas and 11.7% (11.6 to 11.8) in the
least deprived areas. The prevalence of ever-diagnosed currently treated asthma during 2013
was 7.2% (7.1 to 7.2), ranging from 7.7% (7.6 to 7.8) to 6.8% (6.7 to 6.9) in the most and least
deprived areas, respectively.
The study cohort included 106,926 patients (534,630 person-years) with ever-diagnosed,
continuously treated asthma. Patient selection flowchart is shown in S2 Text, and Table 2
shows the patients’ characteristics. Females comprised 56.3% of patients (58.9% to 54.2% in
the most and least deprived areas). Mean age was 47.5 years (SD = 20.3).
Patients in the most deprived quintile (WIMD 1) represented the highest proportion
(23.4%) of the study cohort and were younger overall (mean age = 45.6 years, SD = 20.1) than
those in the least deprived areas (48.8 years, SD = 20.4). At least 1 asthma-related GP consulta-
tion and 1 asthma review was recorded over the follow-up period for 98.5% and 95.0% of
patients, respectively. Only 2.4% and 3.6% had asthma-related A&E attendances and hospitali-
sations during the follow-up period.
Table 3 and Fig 1 show the estimated associations of the WIMD 2011 quintile with asthma-
related primary and secondary care utilisation controlled for age and gender. The count
regression models showed good fit to the data (see S2 Fig). The estimates did not significantly
change by relaxing the patient selection criteria to also include patients with any asthma treat-
ment status or any follow-up periods in the primary care dataset (see S3 Text).
Table 1. Characteristics of the source population in 2013 across the WIMD 2011 quintiles.
Ever-diagnosed asthma Ever-diagnosed currently treated asthma
WIMD quintile Denominator Cases Prevalence % (95% CI) Cases Prevalence % (95% CI)
Most deprived 481,660 60,441 12.5 (12.5, 12.6) 37,142 7.7 (7.6, 7.8)
Next most deprived 442,844 53,531 12.1 (12.0, 12.2) 32,719 7.4 (7.3, 7.5)
Middle deprivation 457,244 52,917 11.6 (11.5, 11.7) 32,307 7.1 (7.0, 7.1)
Next least deprived 399,188 45,763 11.5 (11.4, 11.6) 27,344 6.8 (6.8, 6.9)
Least deprived 467,111 54,649 11.7 (11.6, 11.8) 31,865 6.8 (6.7, 6.9)
All 2,248,047 267,301 11.9 (11.8, 11.9) 161,377 7.2 (7.1, 7.2)
CI, confidence interval; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.t001
PLOS MEDICINE Asthma socioeconomic inequalities in Wales
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003497 February 12, 2021 6 / 27
Asthma-related primary care consultations and reviews
The most deprived quintile (WIMD 1) had %1.9 fewer GP consultations (IRR = 0.98 [95% CI,
0.97 to 0.99], p-value< 0.001) and %2.0 fewer routine asthma reviews (IRR = 0.98 [95% CI,
0.97 to 0.99], p-value< 0.001) per patient compared with the least deprived quintile (WIMD
Table 2. Characteristics of the study cohort.
Most deprived Next most deprived Middle deprivation Next least deprived Least deprived All
(WIMD 1) (WIMD 2) (WIMD 3) (WIMD 4) (WIMD 5)
Number of patients 24,999 (23.4%) 21,921 (20.5%) 21,731 (20.3%) 17,716 (16.6%) 20,559 (19.2%) 106,926 (100.0%)
Females 58.9% 57.0% 55.5% 55.2% 54.2% 56.3%
Age 45.6 (20.1) 46.9 (20.1) 48.0 (20.5) 48.6 (20.4) 48.8 (20.4) 47.5 (20.3)
Asthma-related GP
consultations
1.33, 1.2 (0.8–1.8) 1.35, 1.2 (0.8–1.8) 1.35, 1.2 (0.8–1.8) 1.36, 1.2 (0.8–1.8) 1.35, 1.2 (0.8–1.8) 1.35, 1.2 (0.8–1.8)
98.3% 98.5% 98.5% 98.6% 98.9% 98.5%
Asthma reviews 0.77, 0.8 (0.4–1) 0.76, 0.8 (0.4–1) 0.75, 0.8 (0.4–1) 0.74, 0.8 (0.4–1) 0.79, 0.8 (0.6–1) 0.76, 0.8 (0.4–1)
94.2% 94.7% 94.7% 95.1% 96.4% 95.0%
Asthma-related A&E
attendances
0.008, 0 (0–0) 0.007, 0 (0–0) 0.007, 0 (0–0) 0.006, 0 (0–0) 0.005, 0 (0–0) 0.007, 0 (0–0)
2.5% 2.5% 2.6% 2.3% 2.0% 2.4%
Asthma hospitalisations
Total 0.021, 0 (0–0) 0.015, 0 (0–0) 0.014, 0 (0–0) 0.010, 0 (0–0) 0.009, 0 (0–0) 0.014, 0 (0–0)
4.4% 3.9% 3.4% 3.0% 2.8% 3.6%
Emergency 0.014, 0 (0–0) 0.012, 0 (0–0) 0.010, 0 (0–0) 0.009, 0 (0–0) 0.008, 0 (0–0) 0.011, 0 (0–0)
4.2% 3.7% 3.3% 3.0% 2.7% 3.4%
LOS 0.055, 0 (0–0) 0.052, 0 (0–0) 0.041, 0 (0–0) 0.035, 0 (0–0) 0.032, 0 (0–0) 0.044, 0 (0–0)
Prescriptions
SABA inhalers 7.26, 6.6 (3.4–10.6) 6.45, 5.6 (2.8–9.6) 5.74, 4.6 (2.2–8.4) 5.27, 4.0 (2–7.6) 4.63, 3.4 (1.8–6.4) 5.95, 4.8 (2.4–8.8)
98.5% 97.9% 97.3% 97.4% 97.5% 97.7%
ICS inhalers 2.15, 0.0 (0–3.4) 2.03, 0.0 (0–3.2) 1.94, 0.0 (0–3.0) 1.92, 0.2 (0–3.0) 1.84, 0.2 (0–2.8) 1.99, 0.0 (0–3.0)
48.5% 49.0% 49.9% 51.1% 51.1% 49.8%
ICS-LABA inhalers 5.12, 4.4 (0–9.4) 4.78, 4.0 (0–8.6) 4.47, 3.4 (0–8.0) 4.12, 3.0 (0–7.2) 3.86, 2.8 (0–6.8) 4.51, 3.4 (0–8.2)
68.4% 66.9% 65.1% 63.4% 63.1% 65.6%
Sodium cromoglicate 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0)
0.0% 0.0% 0.1% 0.1% 0.1% 0.1%
Nedocromil 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0) 0.0, 0 (0–0)
0.0% 0.1% 0.0% 0.0% 0.0% 0.0%
LTRA 1.09, 0 (0–0) 1.01, 0 (0–0) 0.86, 0 (0–0) 0.76, 0 (0–0) 0.71, 0 (0–0) 0.90, 0 (0–0)
17.8% 16.5% 15.5% 14.2% 14.5% 15.8%
Theophylline 0.27, 0 (0–0) 0.24, 0 (0–0) 0.20, 0 (0–0) 0.18, 0 (0–0) 0.10, 0 (0–0) 0.20, 0 (0–0)
3.0% 2.7% 2.4% 2.2% 1.3% 2.4%
Oral corticosteroids 0.73, 0.2 (0–0.6) 0.68, 0.2 (0–0.6) 0.70, 0.2 (0–0.6) 0.66, 0.2 (0–0.6) 0.52, 0 (0–0.4) 0.66, 0.2 (0–0.6)
54.6% 53.1% 52.2% 51.5% 47.0% 51.8%












Age at the start of follow-up is presented in years as mean (SD). Average health resource utilisation and prescriptions per year over the 5-year follow-up period is
presented as mean, median (Q1–Q3), and percentage of patients with at least 1 event over the 5-year follow-up period. AMR is the ratio of controller asthma
medications to total asthma medications [27].
A&E, accident and emergency; AMR, asthma medication ratio; GP, general practitioner; ICS, inhaled corticosteroid; IQR, interquartile range; LABA, long-acting beta
adrenoceptor agonist; LOS, length of stay; LTRA, leukotriene receptor antagonists; SABA, short-acting beta agonist; SD, standard deviation; WIMD, Welsh Index of
Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.t002
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Table 3. IRRs with 95% CIs of asthma health service utilisation in each of the WIMD 2011 quintiles relative to the least deprived quintile (fifth quintile), controlled




Asthma reviews Asthma A&E
attendances
Total Emergency LOS
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A&E, accident and emergency; CI, confidence interval; GP, general practitioner; IRR, incidence rate ratio; LOS, length of hospital stay; WIMD, Welsh Index of Multiple
Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.t003
Fig 1. IRRs with 95% CIs of asthma health service utilisation in each of the WIMD 2011 quintiles relative to the least
deprived quintile, controlled for age and gender. Note: The CIs for GP consultations and review are extremely narrow and may
not be obvious in the plot. A&E, accident and emergency; CI, confidence interval; GP, general practitioner; IRR, incidence rate
ratio; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g001
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5). The WIMD quintiles 2 to 4 were also associated with slightly fewer asthma reviews than the
least deprived quintile. The corresponding GAMs support these association patterns (Fig 2).
Less geographical access to services was associated with slightly more asthma GP consultations
and slightly fewer asthma reviews (Fig 3). Overall, females had 2.4% more asthma-related GP
consultations (IRR = 1.02 [1.02 to 1.03], p-value< 0.001) and 5.0% more asthma reviews (1.05
[1.04 to 1.06], p-value< 0.001) than males. However, these gender gaps had minor variations
across the overall WIMD score (Figs 4 and 5) and age: In middle age, females had slightly
higher rates than males, whereas males had slightly higher rates among children and the older
adults. In both genders, however, there was a minor variation across age, with asthma reviews
being lowest in middle age, whereas the younger people had slightly more asthma-related GP
consultations (Fig 6).
Asthma prescriptions in primary care
Patients in the most deprived areas had more primary care asthma prescriptions, at 17.6 pre-
scriptions per year, compared with 12.0 in the least deprived areas. A socioeconomic gradient
existed for all the classes of asthma medications (Table 2). On average, people from the most
deprived areas received 7.3 reliever (SABA) inhalers and 7.3 controller prescriptions of ICS,
ICS-LABA, sodium cromoglicate, and/or nedocromil per year, whereas those in the least
deprived areas received 4.6 relievers and 5.7 controllers. Patients in the most deprived areas
Fig 2. Smooths from GAMs showing the association of the WIMD 2011 score with asthma-related health service
utilisation. The shaded area represents the 95% CI of effect. A&E, accident and emergency; CI, confidence interval; GAM,
generalised additive model; GP, general practitioner; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g002
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Fig 3. Smooths from separate GAMs of asthma-related health service utilisation variables against scores of the WIMD 2011 domains, controlled for age and
gender. The shaded area represents the 95% CI of effect. A&E, accident and emergency; CI, confidence interval; GAM, generalised additive model; GP, general
practitioner; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g003
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were 3.0 times more likely to have 12 or more SABA inhaler per year (risk ratio = 3.0 [2.8, 3.2],
p-value< 0.001).
Mean AMR (controller-to-total medication ratio) was lower in the most deprived quintile
(0.50) than in the least deprived quintile (0.56; Welch t test p-value< 0.001; ratio of
means = 90.3% [89.6% to 91.0%]; absolute difference in means = 0.054 [0.050 to 0.058]). The
GAM showed that AMR generally decreased with higher WIMD score up to around the over-
all WIMD score of 40 before increasing slightly in the higher WIMD scores (Fig 7). However,
AMR distribution below 0.5 was similar across the WIMD quintiles, whereas fewer patients
had AMR >0.5 in the more deprived quintiles (see the empirical cumulative distribution func-
tion plot in S3 Fig). The variation of AMR across age was greater than across the WIMD score,
with the late teens and early 20s having the lowest values. There was no statistically significant
difference in AMR between males and females (odds ratio: 1.003 [0.989 to 1.017], p-
value = 0.721).
Asthma-related A&E attendances
The most deprived areas had 26.9% more A&E attendances than the least deprived areas
(IRR = 1.27 [1.10 to 1.46], p-value = 0.001). The IRR decreased to 1.23 [1.07, 1.41] after
Fig 4. Difference smooths from GAMs showing gender variations in the effect of the WIMD 2011 score on asthma-
related health service utilisation. The shaded area represents the 95% CI of effect. A positive difference means a higher
effect in females than males. The gender gap was stable for asthma primary care consultations and reviews and variable
for A&E attendances, emergency admissions, and LOS. A&E, accident and emergency; CI, confidence interval; GAM,
generalised additive model; GP, general practitioner; LOS, length of stay; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g004
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controlling for AMR (p-value = 0.004). No gradient existed across the deprivation quintiles,
but there was a contrast between the least deprived quintile and the other more deprived quin-
tiles together, a pattern also seen in the corresponding GAM (Fig 2). Lower education levels
and worse housing were consistently associated with higher attendance rates. Higher rates
were also seen towards lower levels of income, employment, and general health (Fig 3). How-
ever, rates were lower with less geographical access to services and worse physical
environment.
Overall, females had 62.4% more asthma-related A&E attendances than males (IRR = 1.62
[1.48 to 1.78], p-value< 0.001). However, the gender gap was variable across age and depriva-
tion; in middle age, females had higher rates than males, whereas males had higher rates in
childhood and also among the older adults living in the most deprived areas (Figs 5 and 8).
Overall, rates were highest in the youngest patients and steeply decreased in older ages (Figs 5
and 6).
Asthma hospitalisations
A steep socioeconomic gradient existed for emergency and total asthma-related hospitalisa-
tions (Figs 1 and 2). Patients in the most deprived quintile were 55.9% more likely to require
emergency admissions for asthma (IRR = 1.56 [1.38 to 1.76], p-value< 0.001) than those in
the least deprived quintile. The IRR decreased to 1.52 [1.35 to 1.72] after controlling for AMR
(p-value< 0.001). Patients in the most deprived quintile were 97.7% more likely to require any
hospitalisation (whether emergency or elective) for asthma (IRR = 1.98 [1.74 to 2.25], p-
value < 0.001) than those in the least deprived quintile. Asthma patients in the most deprived
areas had 64.0% longer asthma-related hospital stay than those in the least deprived areas
Fig 5. Full tensor product smooths from GAMs of asthma-related health service utilisation showing interaction between the WIMD 2011 score and age in males
and females. The colour represents the partial effect (blue = lower, red = higher). The models did not include separate smooths for the WIMD 2011 score and age. A&E,
accident and emergency; CI, confidence interval; GAM, generalised additive model; GP, general practitioner; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g005
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(mean of 0.25 versus 0.15 days during the 5-year follow-up period, respectively; IRR = 1.64
[1.39 to 1.94], p-value< 0.001). The GAMs support these patterns, although they show varia-
tion within the most deprived quintile with the highest admission rates being around the
Fig 6. Smooths from GAMs showing the variation in asthma-related health service utilisation across age. The shaded
area represents the 95% CI of effect. A&E, accident and emergency; CI, confidence interval; GAM, generalised additive
model; GP, general practitioner.
https://doi.org/10.1371/journal.pmed.1003497.g006
Fig 7. A GAM of AMR by the WIMD 2011 score and age, adjusted for gender. The shaded area represents the 95%
CI of effect. AMR, asthma medication ratio; CI, confidence interval; GAM, generalised additive model; WIMD, Welsh
Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g007
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overall WIMD score of 60 (Fig 2). Higher rates of emergency admissions were associated with
worse scores in all the WIMD domains except housing. However, the rates decreased with less
geographical access to services (Fig 3). At the WIMD quintile level, however, the most
deprived quintile had the lowest proportion of emergency-to-total asthma-related admissions
(66.2%), whereas the least deprived quintile had the highest proportion (85.4%, S4 Fig). In the
whole cohort, 57.1% of the nonemergency admissions were day cases with no overnight stay.
Overall, females had 66.7% more emergency admissions (1.67 [1.54 to 1.80], p-
value < 0.001), 60.6% more total hospitalisations (1.61 [1.48 to 1.75], p-value< 0.001), and
98.2% longer hospital stay related to asthma (1.98 [1.77 to 2.22], p-value < 0.001) than males.
However, the gender gap showed some variations across the overall WIMD score and age;
females had higher admission rates and longer hospital stay in middle age and also among the
most deprived older adults, whereas males had higher rates among children and also among
the less deprived older adults (Figs 5 and 8).
Children, especially males, had higher asthma admissions rates and longer stay in hospital
than the other age groups (Fig 6).
Fig 8. Predicted 5-year counts of health service utilisation events for the median age in males and females based on GAMs of
asthma-related health service utilisation by the WIMD 2011 score. The shaded areas represent the 95% CIs of predicted
counts. A&E = general practitioner; GP = general practitioner; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g008
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Asthma-related deaths
In the wider cohort of 327,906 asthma patients, 543 had death with any mention of asthma
and 207 had death with asthma as the underlying cause over the study period. Risk of death
with either definitions generally increased with higher deprivation (Fig 9). Asthma patients in
the most deprived quintile were 56.3% more likely to have death with any mention of asthma
within 5 years than those in the least deprived areas (risk ratio, RR = 1.56 [1.18 to 2.07], p-
value = 0.002, Table 4). When asthma deaths were identified by the underlying cause only, we
could not detect differences between the least deprived and other quintiles, although deaths
were associated with the overall WIMD score (Fig 9).
Among females, risk of asthma deaths generally increased with deprivation, whereas
among males, the highest risk was in the middle WIMD quintile (around the score of 19, Fig
10). Females were generally at higher risk of asthma deaths (Fig 11). However, the gender gap
varied across the overall WIMD score and was wider (i.e., females having higher risk) in the
most deprived (risk ratios for deaths with asthma as the underlying cause, RR = 4.16 [1.76 to
9.80], p-value = 0.001) and in the least deprived quintiles (2.74 [1.20 to 6.24], p-value = 0.016)
and diminished in the middle deprivation quintile where the WIMD score tended to have a
stronger effect among males (Fig 12). However, among the younger patients in the least
deprived areas, males had higher risk of death than females (Fig 13).
Generally, older age and higher deprivation were associated with high risk of asthma deaths. How-
ever, in males over the age of 75 years, lower deprivation was associated with higher risk (Fig 13).
Finally, deaths with asthma as the underlying cause were associated with lower income and
employment levels, and there was weaker evidence that these deaths were associated with
lower health and education levels. However, deaths with any mention of asthma were associ-
ated with lower scores in all those 4 domains (Fig 14).
Discussion
Main findings
We identified worse asthma outcomes for people in the most deprived areas of Wales across
all stages of patient care. Compared with those in the least deprived areas, the most deprived
Fig 9. Smooths from GAMs of asthma deaths by the WIMD 2011 score, controlled for age and gender. The shaded
area represents the 95% CI of effect. CI, confidence interval; GAM, generalised additive model; WIMD, Welsh Index of
Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g009
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group had slightly less asthma-related unscheduled primary care, slightly less structured proac-
tive asthma care, and poorer quality of prescribing, but a markedly higher asthma-related A&E
attendances, hospitalisations, and risk of asthma-related death. Clear socioeconomic gradients
existed in emergency admissions, hospital days, and death. Moreover, higher deprivation was
associated with more asthma prescriptions, higher risk of the excessive use of reliever inhalers,
and prescribing of fewer controller medications relative to reliever inhalers. Lower levels of
income, education, employment, and general health were generally associated with higher
rates of asthma emergency care and death. However, patients in rural areas used less asthma
emergency care. Lastly, females in middle age had higher asthma-related primary and second-
ary care utilisation than males and higher risk of deaths among all adults, although the inverse
patterns were seen in children, and variable patterns existed in the older ages.
Interpretation of findings and comparison with other studies
A complex relationship potentially exists between the WIMD 2011 and asthma outcomes.
Asthma is among limiting, long-term illnesses that contribute to the WIMD 2011 health
domain [22]. The WIMD also incorporates birth outcomes, including low birth weight and
preterm delivery [22]—factors linked to maternal asthma severity and medications [37–39].
Asthma also potentially affects the WIMD education and employment domains as it is linked
Table 4. Risk ratio of asthma deaths by age and gender within the WIMD 2011 score quintiles.
Any mention of asthma Asthma as the underlying cause
Risk ratio (95% CI) p-value Risk ratio (95% CI) p-value
Deprivation quintile: the reference quintile is the least deprived (WIMD 5)
Most deprived (WIMD 1) 1.56 (1.18, 2.07) 0.002 1.39 (0.91, 2.13) 0.124
Next most deprived (WIMD 2) 1.45 (1.09, 1.92) 0.010 1.17 (0.76, 1.82) 0.470
Middle deprivation (WIMD 3) 1.36 (1.02, 1.80) 0.034 0.97 (0.62, 1.52) 0.895
Next least deprived (WIMD 4) 1.49 (1.13, 1.98) 0.005 1.18 (0.76, 1.83) 0.466
Gender (female) 1.21 (1.01, 1.45) 0.042 1.52 (1.12, 2.07) 0.007
Age 1.10 (1.09, 1.10) <0.001 1.09 (1.08, 1.11) <0.001
Within-quintile models
Most deprived
Female 1.84 (1.20, 2.81) 0.005 4.16 (1.76, 9.80) 0.001
Age 1.09 (1.07, 1.10) <0.001 1.08 (1.06, 1.10) <0.001
Next most deprived
Female 1.15 (0.77, 1.70) 0.495 1.49 (0.76, 2.93) 0.245
Age 1.09 (1.08, 1.11) <0.001 1.08 (1.06, 1.11) <0.001
Middle deprivation
Female 0.80 (0.55, 1.17) 0.249 0.55 (0.28, 1.05) 0.069
Age 1.09 (1.08, 1.10) <0.001 1.10 (1.07, 1.12) <0.001
Next least deprived
Female 1.07 (0.73, 1.59) 0.721 1.12 (0.58, 2.14) 0.741
Age 1.12 (1.10, 1.13) <0.001 1.12 (1.09, 1.14) <0.001
Least deprived
Female 1.58 (0.98, 2.54) 0.059 2.74 (1.20, 6.24) 0.016
Age 1.11 (1.09, 1.13) <0.001 1.12 (1.09, 1.15) <0.001
Age was measured in years.
CI, confidence interval; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.t004
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to school absenteeism [40] and job absenteeism and loss [41]. With the above direct and indi-
rect links between asthma and the WIMD 2011, predicting asthma outcomes by the WIMD
requires cautious interpretation of the findings. The socioeconomic variation in asthma-
related primary care consultations and structured asthma review is marginal and may have no
Fig 10. Smooths from GAMs showing the association of the WIMD 2011 score on asthma death in males and
females. The shaded area represents the 95% CI of effect. CI, confidence interval; GAM, generalised additive model;
WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g010
Fig 11. Estimated 5-year risk of asthma deaths for median age in males and females by the WIMD 2011 score. The
shaded area represents the 95% CI of risk. CI, confidence interval; Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g011
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Fig 12. Difference smooths from GAMs showing a varying gender gap in the effect of WIMD 2011 score on
asthma deaths. The shaded area represents the 95% CI of difference in effect. A positive difference means a higher
effect in females than males. CI, confidence interval; GAM, generalised additive model; WIMD, Welsh Index of
Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g012
Fig 13. Full tensor product smooths from GAMs of asthma deaths by the WIMD 2011 score and age in males and
females. The colour represents the partial effect (blue = lower, red = higher). The models did not include separate
smooths for the WIMD 2011 score and age. Generally, higher deprivation and older age were associated with higher
risk of asthma deaths. However, in males over the age of 75 years, lower deprivation was associated with higher risk.
GAM, generalised additive model; WIMD, Welsh Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g013
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clinical significance. However, the wider gap in emergency asthma care and deaths indicates
inequalities in disease severity and potentially in how the disease is managed. Higher asthma-
related health service utilisation, especially in secondary care, often indicates more severe and/
or uncontrolled disease [42].
The higher asthma-related A&E attendances in the most deprived areas might not be solely
driven by more severe or worse controlled disease, but also by a complex host of factors includ-
ing poorer inhaler technique and/or greater other medical/social problems (e.g., comorbidi-
ties) that worsens asthma experience. In addition, some of those A&E attendances could be
driven by the tendency of people, particularly in the more deprived areas, to use A&E depart-
ments as primary care facilities. This could be possibly due to insufficient health literacy [43],
which is consistent with the higher A&E attendances with lower education levels seen in our
study, and/or due to GP practices and pharmacies being overcrowded or inaccessible [44–46].
Accordingly, the socioeconomic contrast in asthma-related A&E attendances could overesti-
mate the gap in asthma severity and control. Nonetheless, this gap is still evident from the
clear socioeconomic gradient in asthma-related emergency admissions and deaths. However,
areas with fewer local services and transport nodes, i.e., rural areas, had lower A&E atten-
dances and admissions for asthma and slightly higher unscheduled asthma GP consultations.
This may suggest that emergency care could be less accessible by those who need it who instead
seek it in primary care. However, it could also be explained by the inverse correlation between
the geographical access to services and the income and education levels which, as our study
shows, are, in turn, inversely associated with asthma emergency care.
The 1.56 [1.18 to 2.07] risk ratio of asthma-related death between the most deprived com-
pared to the least deprived quintiles was an average across age groups. An analysis of asthma
deaths in England found similar relative risk for patients�45 years old (IRRs between 1.30
and 1.37) [3]. However, in that analysis, this pattern was unexpectedly reversed among the
younger patients (IRR = 0.81 [0.69, 0.96]), but this was not seen in our study. Instead, the
interaction we modelled between the WIMD 2011 score and age showed that among the over
75-year-old males, higher deprivation was associated with lower risk of emergency asthma
admissions and deaths.
The gap in asthma severity and control could be explained by factors related to the disease,
patient, and healthcare. Lack of education opportunities may have resulted in lower educa-
tional attainment and health literacy. This may hinder asthma self-management, adherence to
treatment, proper inhaler technique, and engagement in clinical decision-making [10–12],
leading to poorer asthma control and higher dependency on healthcare, including a greater
need for A&E attendances and emergency admissions [47]. The modestly higher use of both
controller and reliever prescriptions with higher overall deprivation is consistent with a gradi-
ent in asthma severity and/or control. However, the corresponding inverse gradient of lower
controller-to-total medication ratio—a measure of whether controllers are adequate relative to
relievers—with higher deprivation suggests variations in prescribing, dosing, adherence, and/
or asthma self-management [48].
Air pollution, a sub-domain in the WIMD 2011 [22], is a possible contributor to socioeco-
nomic inequalities in asthma outcomes. A previous study in Wales found that independent
measures of air pollution had weak to modest effects on “serious” asthma admissions—pro-
longed admissions or those followed by death from any cause [19]. While there is
Fig 14. GAMs of asthma death by the scores of WIMD 2011 domains, controlled for age and gender. The shaded
area represents the 95% CI of effect. CI, confidence interval; GAM, generalised additive model; WIMD, Welsh Index of
Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003497.g014
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contradictory literature about the effect of air pollution on asthma incidence and prevalence
[15,16], it was associated with higher risk of exacerbations, especially in those who live or
spend time close to busy roads [13,14].
Females, especially between the age of 16 and 60 years, are generally overrepresented in pri-
mary care [49]. Nonetheless, in our study, the gender gap in asthma-related primary care con-
sultations was minimal. However, females had higher rates of asthma-related A&E
attendances, admissions in middle age, and higher risk of asthma deaths among all adults, with
the inverse pattern in childhood, which is generally consistent with other studies [50–54].
These patterns could be driven by gender differences in asthma development, disease experi-
ence, and outcomes [55,56].
Strength and limitations
Our study has several strengths. We used objective, real-world, person-level data with high to
complete nationwide representativeness to identify most people with asthma in Wales and
individually measure their asthma-related health service use. Free-of-charge healthcare,
including prescriptions, limits the potential bias of patients on low income avoiding healthcare
access to minimise out-of-pocket expenses [57,58]. The 2011 WIMD incorporated multiface-
ted deprivation domains for small areas in Wales, enabling a comprehensive assessment of
socioeconomic status. We explored both the WIMD score, which allowed exploring nonlinear
associations, and its quintiles. The latter approach is commonly used in the assessment of
health inequalities [3,59,60]. However, it involves information loss and other methodological
problems [61]. Nonetheless, in our study, both approaches led to generally consistent findings.
Finally, modelling by the WIMD 2011 individual domains, each in a separate model, has pro-
vided additional insights into the drivers of asthma inequalities, which should however be
interpreted in the light of collinearity between some of these domains, particularly income,
employment, education, and health.
Our study has some limitations. The WIMD 2011 is an area-level index [22], and therefore,
caution is required when drawing person-level inferences. However, our findings are generally
consistent with other studies in the UK and elsewhere which have found similar gaps of higher
incidence of asthma symptoms and emergency hospitalisations and higher asthma severity in
the more deprived areas [3,62–64]. Excluding patients with gaps in their primary care data
from our cohort reduced the possibility of missing primary care data while insignificantly
affecting the findings, as shown in the sensitivity analysis. However, this means people who
died within the follow-up period, who might have more severe disease, were excluded from
the main cohort in which health service utilisation was investigated. We did not exclude
patients with diagnosis of chronic obstructive pulmonary disease (COPD), which may coexist
with asthma, resulting in more severe symptoms and higher health service utilisation and mor-
tality in the older ages [65–67]. The AMR formula is based on the number of prescriptions
which did not necessarily reflect the actual prescribed dosage (puffs per day). However, data
on actual dosage are currently not available in the primary care dataset that we have used.
Residual confounders and mediators might have been involved in some of the observed associ-
ations in our study. Smoking is for example associated with socioeconomic deprivation [68].
The National Survey for Wales in 2016 to 2017 has found that adults in the most deprived
quintile were 3 times more likely to smoke than those in the least deprived quintile [69]. Smok-
ing is associated with a number of limiting long-term illnesses which were accounted for in the
WIMD 2011 health domain. Smoking is also associated with poor asthma outcomes. Exposure
to secondhand tobacco smoke among children with asthma is associated with reduction in
pulmonary function and doubles the risk of hospitalisation for asthma exacerbation [70].
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Therefore, differential smoking status might have partially mediated and confounded the
observed association between socioeconomic deprivation and asthma-related health service
utilisation, especially in secondary care. Asthma is also associated with a range of comorbidi-
ties, such as obesity and depression, which are associated with higher asthma severity and
lower control and in which a socioeconomic gradient has been observed [71,72]. However, we
did not control for the potential confounding effect of comorbidities.
Implication for research, clinical practice, and public policy
The socioeconomic disparities that we have found in asthma-related health service utilisation
highlight the need for multifaceted service improvement. Strategies are needed to aid optimal
prescribing and prevent the excessive use of reliever inhalers [73]. In addition, the most
deprived groups may require more effective health education on asthma self-management,
including inhaler technique, adherence to treatment, and avoidance of triggers. However,
those interventions alone are unlikely to bridge the socioeconomic gap in asthma outcomes.
Rather, structural and social determinants, including the circumstances in which people are
born and live, play a crucial role in asthma outcomes [74]. As with health inequalities in gen-
eral, inequalities in asthma should ultimately be addressed by achieving equitable wider socie-
tal determinants of health, particularly educational opportunities, housing, and health service
resourcing [75].
Avoidable health inequalities, in addition to being unfair, potentially waste resources.
Given the high prevalence of asthma in Wales, even the modest gap in asthma health service
utilisation, especially in secondary care, would result in avoidable, significant disease costs at
the country level. To better understand and therefore tackle asthma inequalities, further
research is needed to identify the most significant and modifiable determinants, estimate their
avoidable financial cost to the public sector, and identify the most cost-effective service and
public health interventions to reduce these inequalities and their burden.
Conclusions
In conclusion, we have found consistent socioeconomic variations in asthma health service
utilisation, prescribing, and death in Wales across all stages of patient care. Patients in the
most deprived areas had poorer prescribing and were over 1.5 times more likely to both be
urgently admitted to hospital and to die due to asthma compared with the least deprived areas.
These inequalities are associated with avoidable harm and deaths to patients and costs to
Wales. There is a pressing need to develop targeted service interventions and much wider soci-
etal policies to tackle such health inequalities.
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